A team of experts to tackle challenges in inhalation drug delivery

Board of directors

Empy thumbnail
Elijah Nazarzadeh
Dr. Elijah Nazarzadeh has led Nebu-Flow®’s technology and business development through his postdoctoral research at the University of Glasgow. Elijah started the business development by securing an Innovate UK’s ICURe programme  and was subsequently awarded an Unlocking Ambition Fellowship, supported by the Scottish Government, from the Royal Society of Edinburgh.
Empy thumbnail
John Pritchard
Dr. John Pritchard has more than 25 years of experience in the field working for GSK, AstraZeneca, 3M and Philips. He received the Charles Thiel Award from Virginia Commonwealth University for outstanding research and discovery in respiratory drug delivery in 2018.
Duncan Thorburn
Duncan is an Investment Manager at Foresight Group. Prior to joining Foresight, Duncan worked in corporate finance assisting SMEs with M&A and fundraising mandates, with a focus in the tech sector. Duncan is a qualified Chartered Accountant with the Institute of Chartered Accountants Scotland and holds an MA in Business Studies and Accounting from the University of Edinburgh.
Dr Harry Destecroix
Harry is the founder of the Science Creates ecosystem and Managing Partner of Science Creates Ventures. He is a scientist, entrepreneur and investor, and the co-founder of Ziylo, the hugely successful University of Bristol spin-out company. Harry is passionate about building great companies and providing the optimum ecosystem to facilitate their growth and development.
Prof. Jon Cooper FREng FRSE
Professor Cooper has already spun successful companies from his research, including Mode-Dx (who signed an agreement with Boots covering bowel cancer diagnostics) and Clyde Biosciences (developing drug screening with three pharmaceutical companies).

Advisory Board

Dr. Gary Pitcairn
Dr Gary Pitcairn is an experienced senior leader, with a successful track record of leading global multidisciplinary teams. Gary is a recognised expert in the field of inhaled drug delivery with extensive device experience in both nebulisers and inhalers. Gary also has proven product development experience, from pre-clinical through to late phase.
Dr. Helen Erwood
Regulatory Advisor
Dr. Helen Erwood, Director of ESPL, has nearly 30 years of experience in regulatory affairs working for ICI Pharmaceuticals (now Astra-Zeneca), Rhone Poulenc Rorer (now Sanofi Aventis) and SmithKline Beecham Consumer Healthcare (now GSK Consumer).
Dr. Helen Muirhead FRSC
Dr. Helen Muirhead is a Fellow of the Royal Society of Chemistry with 42 years of experience of both R&D and Manufacturing, including 30 years at GSK. Helen headed up the Respiratory Centre of Excellence during the late stages of Product Development through Regulatory Filing and Commercial Launch and supply of new Medicines.
Dr. Julien Reboud
Scientific Advisor
Dr. Julien Reboud, a co-founder of Nebu-Flow®, is Senior Lecturer at the University of Glasgow. He is joint winner of the Royal Academy of Engineering ERA Foundation Entrepreneurs Award. Julien brings a long track record of research and application of the SAW technology.
Prof. Dr. Gordon Muirhead GSK Emeritus Senior Fellow
Prof. Dr. Gordon Muirhead has more than 20 years of experience in senior roles at GlaxoSmithKline (GSK) including 12 years as Vice President of Global New Medicines Introduction within the Global Manufacturing and Supply division of GSK.

In office team

Empy thumbnail
Awadhesh Singh
Awadhesh is an accomplished Engineering Project Manager with over 8 years of experience in R&D engineering and product development. With a strong background in highly scientific laboratory and medical devices, Awadhesh brings a wealth of expertise to the table. His qualifications include an MBA in Strategy & FinTech, an MSc in Data Science, PGD in Business Analyst and a B. Tech in Electrical and Electronics Engineering. Awadhesh has successfully led teams of engineers and researchers, managing projects from start to finish while resolving technical and non-technical issues. His skills encompass strategic planning, project management, data analytics, and problem-solving.
Empy thumbnail
Christian Witte
Christian earned a PhD in Biomedical Engineering from the University of Glasgow and a Masters degree in Biosystems Technology and Bioinformatics from the Technical University of Applied Sciences Wildau, Germany. His research expertise includes biosensor technologies and the application of acoustofluidic and electrokinetic phenomena for micro and nano-scale manipulations. As a valued member of the Nebu-Flow® team, he utilizes his knowledge to develop the core technology and navigate the complex regulatory landscape of medical device development.
Empy thumbnail
David Tatnell
David completed his PhD at University of Exeter, where he studied the thermoacoustic generation of ultrasound via Joule heating in thin films. In particular, he demonstrated how the unique characteristics of such sound sources make them ideal for application in ultrasonic phased arrays.
Graham Matthews
Graham brings 20 years of experience working in the field of aerosol drug delivery. Much of this time has been spent establishing collaborations with pharma companies, supporting the evaluations of potential delivery devices with their drug and supplying products for both clinical trials and commercially.
Habib Nassar
Habib got his Bachelors degree in Electronics and Communications Engineering from the University of York and his Masters degree in Biomedical Engineering from the University of Glasgow. He has a PhD in Electronics and Electrical Engineering from the University of Glasgow where he developed novel embedded electronic systems for affordable, user-centred, and environmentally sustainable biomedical devices.
Rabeeah Habib
Rabeeah is a Mechanical Engineer with a PhD from the University of Glasgow. His PhD research has been published in five journal articles and presented at the 16th UK National Heat Transfer conference held at the University of Nottingham in 2019. Rabeeah is passionate about using his skills to make a difference, evident in his latest research project at the Queen Mary University of London on the RELIANT COVID-19 related project, which focused on evaluating the risk of infection in indoor environments.
Our culture

We are Nebu~Flow®

Our people are passionate about the development of products with a positive impact on the lives of patients, whilst considering sustainability and the future of our planet at the heart of our activities. We are a diverse and knowledgeable team, focused on patient-centric healthcare and creating innovative products to address the need of both healthcare systems and the pharmaceutical industry. Moreover, we are committed to establishing an inclusive workspace that values everyone equally.

This website uses cookies. Learn more on our Privacy Policy